Work

MA16.09 Antitumor Activity and Safety of Crizotinib in Patients with MET Exon 14-Altered Advanced Non-Small Cell Lung Cancer

Year: 2017

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2016.11.512

Authors: Alex Drilon, Sai-Hong Ou, Jeffrey Clark, D. Ross Camidge, Mark Socinski, Jared Weiss, Benjamin Solomon, Gregory Riely, Rebecca Heist, Geoffrey Shapiro, Sherry Wang, Maria Winter, Katherine Monti, Keith Wilner, Paul Paik

Institutions: Memorial Sloan Kettering Cancer Center, University of California, Irvine, Massachusetts General Hospital, University of Colorado Cancer Center, University of Pittsburgh Medical Center, UNC Lineberger Comprehensive Cancer Center, Peter MacCallum Cancer Centre, Dana-Farber Cancer Institute, Pfizer (United States), Rho (United States)

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2571208503

Cites:

Cited by: 15

Related to: 10